Core Insights - The WISE 2025 Business King Conference, held on November 27-28, is described as an immersive experience rather than a traditional industry summit, focusing on the intersection of technology and business trends [1] - Roche Pharmaceuticals' AI medical product development team presented a talk on "Xiao Luo Zhi Duo Xing," an AI assistant for clinical researchers, which won the "Annual AI Application Scenario Breakthrough Enterprise" award at the conference [1] Summary by Sections Conference Overview - The conference aims to capture real insights from numerous business practices, highlighting trends from AI reshaping hardware boundaries to brand globalization in the context of overseas expansion [1] Presentation by Roche Pharmaceuticals - The presentation by Chen Shuzhan from Roche Pharmaceuticals focuses on the challenges in clinical research and how AI can assist in overcoming these challenges [3][4] - The product "Xiao Luo Zhi Duo Xing" is designed to be a research companion for clinical doctors, addressing pain points in the research process [4] Research Process Challenges - Clinical research is often tedious and requires significant patience, involving multiple stages: topic selection, project initiation, data management, and manuscript writing [6] - The process can take from six months to two years, with potential setbacks if topics are published by others or if proposals require resubmission [6] AI Solution Features - "Xiao Luo Zhi Duo Xing" offers four main functionalities: intelligent topic selection, simulated peer review, literature interpretation, and research proposal writing, which can save users at least 80% of their time compared to traditional methods [7][8] - The intelligent topic selection feature allows users to input keywords and receive valuable research topics based on existing literature, adhering to evidence-based medicine principles [8] - The simulated peer review function mimics feedback from top journals, helping researchers avoid common mistakes before submission [10] User Adoption and Future Outlook - The product has gained over 4,600 users in six months, indicating strong interest from leading hospitals in China [16] - The company envisions a future where AI will simplify research processes, making them more efficient and enjoyable, with aspirations to create a comprehensive AI research assistant [16][17]

2025年的商业世界正站在新旧转换的十字路口。在商业叙事重构、科技浪潮席卷的当下，WISE2025商业之王大会以"风景这边独好"为基调，试图在不确定中锚定中 国商业的确定性的未来。我们在此记录这场思想盛宴的开篇，捕捉那些在变局中依然坚定前行的声音。 11月27-28日，被誉为"年度科技与商业风向标"的36氪WISE2025商业之王大会，在北京798艺术区传导空间落地。 今年的WISE不再是一场传统意义上的行业峰会，而是一次以"科技爽文短剧"为载体的沉浸式体验。从AI重塑硬件边界，到具身智能叩响真实世界的大门； 从出海浪潮中的品牌全球化，到传统行业装上"赛博义肢"——我们还原的不仅是趋势，更是在捕捉在无数次商业实践中磨炼出的真知。 我们将在接下来的内容中，逐帧拆解这些"爽剧"背后的真实逻辑，一起看尽2025年商业的"风景这边独好"。 11月28日下午，罗氏制药中国医学部AI医疗产品开发团队负责人陈舒展发表题为 《当医学遇到AI小罗智多星：临床医生的"贾维斯"》 的分享，详细解读了 小罗智多星为临床科研带来的便利，值得一提的是，罗氏制药中国也荣获了本届大会"年度AI应用场景突破企业"。 以下为陈舒展的演讲实录，经 ...

Group 1: AI and Technology Transformation - AI is evolving from a tool for process optimization to a core productivity force that reshapes industry logic, marking the transition from "using AI" to "coexisting with AI" [7] - The emergence of embodied intelligence is transforming productivity by enabling robots to autonomously learn and operate in diverse environments, thus integrating AI's value into urban and industrial contexts [9] - The concept of Agentic AI is introduced, where AI evolves from a passive tool to an active collaborator, enhancing decision-making and operational efficiency across industries [16] Group 2: Consumer Behavior and Market Dynamics - The consumer market is undergoing a profound value reconstruction, with consumers balancing rational price-value assessments and emotional connections to brands [34] - The focus is shifting from chasing broad market appeal to creating unique, irreplaceable value for specific consumer segments, as seen in the "胖东来模式" and the rise of domestic brands [35][36] - Companies are urged to prioritize quality and authenticity in their offerings, aligning with consumer expectations for genuine value rather than inflated prices [37] Group 3: Health and Biotechnology - The integration of AI with biology is redefining health management, moving towards personalized solutions that decode individual life patterns and health needs [45] - The concept of "biological intelligence" emerges, emphasizing the collaboration between AI and biological sciences to unlock new potentials in disease treatment and human understanding [46] Group 4: Marketing and Brand Strategy - The marketing landscape is shifting from external traffic acquisition to building internal trust assets, with founders becoming the "trust conduits" for their brands [50] - Long-termism is identified as a foundational logic for brand growth, emphasizing sustained investment in core areas rather than short-term gains [51] - The importance of effective innovation is highlighted, focusing on simplifying choices and enhancing the utility of products rather than merely adding features [66] Group 5: Innovation and Entrepreneurship - The essence of innovation is returning to fundamental business principles, with successful entrepreneurs balancing visionary foresight with rigorous value assessments [59] - The concept of "soft technology" is gaining traction, emphasizing that the ultimate goal of technology is to enhance emotional connections and human welfare [65] Group 6: Global Collaboration and Sustainability - The global AI landscape is evolving towards a model of mutual empowerment, where resources and demands create a value cycle rather than a one-way output [22] - The focus on sustainable development is evident, with industries leveraging AI to create efficient, green manufacturing processes that redefine operational paradigms [25] Group 7: Conclusion and Future Outlook - The WISE2025 conference encapsulates the deep integration of technology and business, highlighting key themes such as AI acceleration, consumer value return, and global collaboration [68] - Trust, quality, and innovation are identified as the cornerstones for navigating uncertainties in the business landscape, emphasizing the role of entrepreneurs as active participants in shaping the future [68]

Group 1: AI and Technology Transformation - AI is evolving from a tool for process optimization to a core productivity driver that reshapes industry logic, moving towards a symbiotic relationship with humans [3][4][5] - The emergence of embodied intelligence signifies a paradigm shift where robots can autonomously learn and operate in diverse environments, integrating AI's value into real-world applications [4][5] - The concept of "Agentic AI" is introduced, where AI transitions from a passive tool to an active collaborator, enhancing decision-making and operational efficiency [11] Group 2: Consumer Behavior and Market Dynamics - The consumer market is undergoing a profound value reconstruction, with consumers balancing rational price-performance assessments and emotional connections to brands [25][27] - Companies are shifting from a focus on mass appeal to creating unique value for specific consumer segments, as seen in the "胖东来模式" and the rise of domestic brands [26][27] - The importance of quality and cultural narratives in consumer choices is emphasized, indicating a trend towards brands that resonate with cultural identity and emotional experiences [25][27][42] Group 3: Innovation and Business Strategy - The focus of innovation is shifting from merely adding features to creating tangible value, with a growing emphasis on effective innovation that simplifies choices for consumers [52] - Companies are encouraged to adopt a long-term perspective, prioritizing sustainable growth and trust-building over short-term gains [39][44] - The integration of AI into business operations is seen as a critical factor for driving efficiency and enhancing customer experiences, marking a transition from traditional practices to data-driven strategies [40][41] Group 4: Health and Biotechnology - The intersection of AI and biology is leading to personalized health solutions, moving towards a model that decodes individual health needs rather than offering generic solutions [33][34] - The concept of "biological intelligence" emerges, highlighting the potential of AI to enhance our understanding of complex biological systems and improve healthcare outcomes [34][37] Group 5: Globalization and Collaboration - The globalization of AI is evolving from a one-way technology transfer to a two-way empowerment ecosystem, fostering collaboration across borders [16] - The narrative of global brands is shifting from competition to co-creation, emphasizing the importance of trust and shared values in building sustainable business relationships [38][39]

Core Insights - The WISE 2025 Business King Conference aims to address the urgent needs of business operators in a fragmented market, focusing on user insights, technology-driven product restructuring, and new strategies for globalization [2][3] - The agenda for the conference on the 28th is designed to outline a comprehensive future business strategy guide [3] Group 1: User Insights and Brand Development - The conference will explore how brands can identify real user needs in a chaotic environment where consumer loyalty is minimal and product life cycles are extremely short [5] - A keynote speech titled "The Moment of Chinese Brands: From 'Presence' to 'Definition Power'" will be delivered by 36Kr's Chief Content Officer, Li Yang [7] - The "Future Super Brand Directory of Domestic Products" will be released, serving as a strategic blueprint for future brand competition [8] Group 2: Methodology and Trends - NielsenIQ's Senior Vice President, Wang Fei, will break down the methodology behind the "Future Super Brand Directory," focusing on measuring current brand presence and predicting future category influence [10] - Zhao Yan, Chairman of Huaxi Group, will discuss the integration of Chinese manufacturing and life sciences, emphasizing the importance of co-evolution with users, technology, and time [13] Group 3: Technology and Brand Innovation - The conference will highlight how technology is transforming consumer products, with a focus on AI as a growth engine for brands [28] - A session will discuss the "Marketing + AI Dual-Drive" model, which is becoming a new paradigm for Chinese companies expanding globally [30] - The importance of integrating technology into traditional consumer products will be emphasized, showcasing practical paths for innovation [34] Group 4: Globalization and Market Strategies - The concept of "ecological symbiosis" will be introduced as a new approach for Chinese companies going global, moving away from merely replicating Chinese models [37] - Insights from NielsenIQ will be shared regarding the new logic of globalization, emphasizing the need for local adaptation and collaboration [39] Group 5: Future Consumer Trends - The final session will present key consumer signals and structural changes expected in 2026, aiming to reveal deeper insights beyond superficial trends [56] - A discussion on the role of personal branding in various industries will be featured, highlighting the importance of founders as brand symbols [60]

Core Viewpoint - The integration of AI in healthcare is revolutionizing the industry, making medical exploration faster and more precise [2][3][15] Group 1: AI's Impact on Healthcare - AI is transforming the healthcare sector, with applications in drug development, medical imaging diagnostics, and clinical decision support systems [3] - The rise of AI is driven by both policy support and market demand, positioning healthcare as a promising core area for AI development [3][12] - Roche is emerging as a key player in the transformation of the healthcare ecosystem, actively embracing AI technologies [3][12] Group 2: Addressing Physician Workload - A significant challenge in healthcare is to free up physicians from administrative burdens to enhance system efficiency [5][6] - The introduction of AI tools like "Xiao Luo Zhi Duo Xing" aims to alleviate the workload of physicians by providing comprehensive research solutions [7][8] - This AI tool has already been implemented in 700 top-tier hospitals across 90 cities, saving over 20,000 hours of research time for more than 4,000 doctors [9] Group 3: Data Management Challenges - Fragmented data across different hospitals complicates the implementation of smart healthcare solutions, creating "information islands" [10] - The clinical documentation process is identified as a high-potential area for AI investment, with a market size of $600 million in the U.S. alone [10] - Roche's collaboration with Fudan University and Shanghai AI Lab has led to the development of the MDT (Multidisciplinary Team) AI tool, which significantly reduces the time needed for patient history organization [10][11] Group 4: Building an AI-Driven Ecosystem - The healthcare sector is seen as one of the most underestimated areas for AI applications, with a vision for universal access to precise diagnostic services [13][14] - Roche emphasizes the importance of integrating AI into clinical applications to address real pain points faced by doctors and patients [14] - The company is committed to creating an open and collaborative medical innovation ecosystem through various initiatives, including the "Knowledge Action Institute" and "Smart Medical Incubator 2.0" [14]

Core Insights - The integration of AI in the medical and pharmaceutical sectors is becoming increasingly prominent, with numerous innovative products showcased at the China International Import Expo, highlighting AI's role in drug development, clinical efficiency, and decision-making [1][2][6]. Group 1: AI Empowerment in Medical Research and Drug Development - The Chinese government has implemented policies to promote AI in the pharmaceutical industry, emphasizing the use of new information technologies in drug research [2]. - Major multinational companies like Roche, AstraZeneca, Johnson & Johnson, and Siemens Healthineers are collaborating with AI firms to advance various projects [2][3]. - Roche's AI-driven solutions, such as the "MDT Intelligent Body" and "Little Roche Smart Star," aim to enhance clinical practice efficiency and support the entire research process, having already assisted over 4,000 doctors in completing more than 600 research projects [3]. Group 2: AI in Medical Devices and Diagnostics - The introduction of AI-powered medical devices is transforming traditional healthcare practices, with companies like Medtronic showcasing their AiBLE smart ecosystem that integrates surgical robots and imaging systems [6]. - Siemens Healthineers presented its AI-driven innovations, including a prostate cancer diagnostic software that enhances detection accuracy and reduces misdiagnosis risks [7]. - Boston Scientific debuted several AI-enabled cardiac health innovations, including the FDA-approved HeartLogic heart failure monitoring system, which can predict heart failure risks [7]. Group 3: Brain-Computer Interface Technology - Brain-computer interface (BCI) technology is emerging as a revolutionary treatment paradigm, enabling patients with severe disabilities to control devices through thought [11][12]. - Siemens Healthineers introduced a comprehensive BCI solution that covers preoperative planning, intraoperative navigation, and postoperative evaluation, facilitating the clinical application of BCI technology [12]. - Medtronic showcased a rechargeable, perceptive closed-loop brain stimulator that offers personalized treatment for conditions like Parkinson's disease, enhancing patient care [12].